Melatonin Anticancer Effects: Review
Open Access
- 24 January 2013
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (2), 2410-2430
- https://doi.org/10.3390/ijms14022410
Abstract
Melatonin (N-acetyl-5-methoxytryptamine, MLT), the main hormone produced by the pineal gland, not only regulates circadian rhythm, but also has antioxidant, anti-ageing and immunomodulatory properties. MLT plays an important role in blood composition, medullary dynamics, platelet genesis, vessel endothelia, and in platelet aggregation, leukocyte formula regulation and hemoglobin synthesis. Its significant atoxic, apoptotic, oncostatic, angiogenetic, differentiating and antiproliferative properties against all solid and liquid tumors have also been documented. Thanks, in fact, to its considerable functional versatility, MLT can exert both direct and indirect anticancer effects in factorial synergy with other differentiating, antiproliferative, immunomodulating and trophic molecules that form part of the anticancer treatment formulated by Luigi Di Bella (Di Bella Method, DBM: somatostatin, retinoids, ascorbic acid, vitamin D3, prolactin inhibitors, chondroitin-sulfate). The interaction between MLT and the DBM molecules counters the multiple processes that characterize the neoplastic phenotype (induction, promotion, progression and/or dissemination, tumoral mutation). All these particular characteristics suggest the use of MLT in oncological diseases.Keywords
This publication has 151 references indexed in Scilit:
- Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16BNature Medicine, 2012
- Radiation‐Induced Reprogramming of Breast Cancer CellsThe International Journal of Cell Cloning, 2012
- Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d’Etude des Lymphomes de l’Adulte (GELA)Annals of Oncology, 2009
- Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp‐9) and effector caspases (casp‐3/casp‐7) and PARP in UVR‐exposed HaCaT keratinocytesJournal of Pineal Research, 2007
- Expression of membrane and nuclear melatonin receptors in mouse peripheral organsLife Sciences, 2004
- Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in n1e-115 cellsExperimental Neurology, 2003
- Evidence for tryptophan hydroxylase and hydroxy-indol-o-methyl-transferase mRNAs in human blood plateletsLife Sciences, 1997
- The RXR heterodimers and orphan receptorsCell, 1995
- Melatonin effect on serotonin uptake and release in rat platelets: diurnal variation in responsivenessLife Sciences, 1993
- Diffuse Well Differentiated Lymphocytic Lymphoma: A Clinical Study of 22 PatientsOncology, 1991